Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French pharmaceutical group specialized in the field of nuclear medicine. The Swiss pharmaceutical company will buy Advanced Accelator Applications in a deal valued at $3.9 billion and in efforts to strengthen its oncology business. The company has entered into a memorandum … Continue reading “Novartis to Buy This Big French Drug Maker for $3.9 Billion”
Biotech & Pharma
Biotech & Pharma
Pfizer to Sell its Consumer Healthcare Business in November
According to a Reuters report which cited two people close to the matter who remain…
October 26, 2017
Biotech & Pharma
Novartis Climbs Higher After Earnings Rise
Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after…
October 24, 2017
Biotech & Pharma
Gilead Shares Move Higher After FDA Approves its Cancer Drug
Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has…
October 19, 2017
Biotech & Pharma
Merck Shares Explode After Citi Upgrade
It was a strong day for pharmaceutical company Merck on Wednesday. The stock's shares started…
October 18, 2017
Biotech & Pharma
Zogenix Shares Double on Epilepsy Treatment Results
Shares of biotech stock Zogenix had an exciting trading day on Friday after the company…
September 29, 2017
Biotech & Pharma
The FDA Has Approved the First Finger Prick-Free Diabetes Device
Millions of Americans may be thrilled to learn that the Food & Drug Administration has…
September 28, 2017
Biotech & Pharma
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
September 25, 2017
Biotech & Pharma
A Test that Can Detect Cocaine in Seconds Using a Fingerprint
Imagine being able to know if someone has been using cocaine recently in just seconds…
September 22, 2017
Biotech & Pharma
This U.S Drug maker Just Said it Will Lay off 20% of Its Workforce
U.S drug maker Alexion announced this week that it would be slashing 20% of its…
September 12, 2017
Biotech & Pharma
This Major Drug Maker Will Cut its Work Force by 9%
Indianapolis-based Eli Lilly announced on Thursday that the company will be cutting almost 9% of…
September 7, 2017
Biotech & Pharma
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
September 4, 2017
Biotech & Pharma
The First FDA Approved Therapy to Fight Leukemia is Here
The FDA has approved a gene therapy treatment for use in the U.S to Novartis…
August 30, 2017
Biotech & Pharma
Pfizer Sees a 50% Rise in Profit with the Help of These Drugs
Top U.S. drug maker Pfizer just reported its second quarter earnings report that beat the…
August 1, 2017